Efficacy and safety of oral semaglutide in Russian patients with type 2 diabetes: subgroup analysis of PIONEER 1, 2, 3 trials
INTRODUCTION. Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are the treatment options with comprehensive action on different aspects of type 2 diabetes. Due to its peptide nature GLP-1 RAs, until recent time the delivery of these agents into patients’ organism was via injectable devices. In 2...
| Հիմնական հեղինակներ: | , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
Endocrinology Research Centre
2022-07-01
|
| Շարք: | Сахарный диабет |
| Խորագրեր: | |
| Առցանց հասանելիություն: | https://www.dia-endojournals.ru/jour/article/view/12941 |